US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Artiva Biotherapeutics, Inc.

6.01

+3.24116.97%

Post-market: 5.51-0.5000-8.32%19:59 EDT

Volume:100.33M

Turnover:604.31M

Market Cap:146.80M

PE:-1.84

High:7.36

Open:5.59

Low:5.14

Close:2.77

52wk High:15.49

52wk Low:1.47

Shares:24.43M

Float Shares:5.38M

Volume Ratio:22.47

T/O Rate:1864.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2618

EPS(LYR):-5.8064

ROE:-86.18%

ROA:-41.57%

PB:0.98

PE(LYR):-1.04

Loading ...

Overview Company News Filings

Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares

Why Is Artiva Biotherapeutics Stock (ARTV) Up 105% Today?

Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA), Artiva Biotherapeutics, Inc. (ARTV) and Perspective Therapeutics (CATX)

Wedbush Adjusts Price Target on Artiva Biotherapeutics to $23 From $18, Maintains Outperform Rating

MT Newswires Live

Artiva Biotherapeutics price target raised to $23 from $18 at Wedbush

BUZZ-U.S. STOCKS ON THE MOVE-Revolution Medicines, Artiva, Jefferies

Artiva Biotherapeutics Price Target Maintained With a $18.00/Share by Needham

Artiva Biotherapeutics: Strategic Positioning in Rheumatoid Arthritis Market with Promising AlloNK Therapy

BUZZ- Artiva surges on US FDA's 'fast track' tag for cell therapy

Artiva Biotherapeutics Shares Double Premarket on US FDA Fast Track Tag for Its Cell Therapy

THOMSON REUTERS

Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK® in Refractory Rheumatoid Arthritis

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

THOMSON REUTERS

Artiva Biotherapeutics Inc - FDA Grants Fast Track Designation to Allonk in Refractory Ra

THOMSON REUTERS

Artiva Biotherapeutics Inc. to Participate in Cantor Global Healthcare Conference 2025

Artiva Biotherapeutics CEO Fred Aslan Reports Disposal of Common Shares

Artiva Biotherapeutics Inc: Files for Mixed Shelf of up to $300 Mln - Filing

THOMSON REUTERS

Artiva Biotherapeutics Q2 EPS $(0.87) Misses $(0.80) Estimate

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

Artiva Biotherapeutics Inc. Concluded Annual Stockholders Meeting

Artiva Biotherapeutics Coverage Assumed by HC Wainwright & Co. at Buy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARTV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":6.01,"timestamp":1760731200000,"preClose":2.77,"halted":0,"volume":100332975,"hourTrading":{"tag":"盘后","latestPrice":5.51,"preClose":6.01,"latestTime":"19:59 EDT","volume":1181831,"amount":6637400.7564,"timestamp":1760745597765},"delay":0,"floatShares":5381708,"shares":24425762,"eps":-3.261806,"marketStatus":"Market Closed","change":3.24,"latestTime":"10-17 16:00:00 EDT","open":5.59,"high":7.36,"low":5.1401,"amount":604307615.417475,"amplitude":0.801408,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.261806,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":2.77,"preHourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":2.77,"latestTime":"09:29 EDT","volume":11218955,"amount":65064447.3215275,"timestamp":1760707799999},"postHourTrading":{"tag":"盘后","latestPrice":5.51,"preClose":6.01,"latestTime":"19:59 EDT","volume":1181831,"amount":6637400.7564,"timestamp":1760745597765},"volumeRatio":22.469384719965134},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":5381708,"roa":"-41.57%","roe":"-86.18%","lyrEps":-5.806365,"volumeRatio":22.469384719965134,"shares":24425762,"dividePrice":0,"high":7.36,"amplitude":0.801408,"preClose":2.77,"low":5.1401,"week52Low":1.47,"pbRate":"0.98","week52High":15.49,"institutionHeld":0,"latestPrice":6.01,"eps":-3.261806,"divideRate":0,"volume":100332975,"delay":0,"ttmEps":-3.261806,"open":5.59,"prevYearClose":10.08,"prevWeekClose":2.81,"prevMonthClose":2.87,"prevQuarterClose":2.87,"fiveDayClose":2.81,"twentyDayClose":2.88,"sixtyDayClose":3.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87},{"market":"US","date":"2025-05-08","symbol":"ARTV","fiscalQuarterEnding":"2025/03","expectedEps":-0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735704000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2025-10-17","current":-1.842538,"percent":0.721854,"low":-11.820615,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"high":-0.499349,"avg":-3.523771,"sd":3.547698,"marketCap":67659360},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360}],"updateTime":1760805316592},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576937710","title":"Artiva Biotherapeutics CEO Fred Aslan Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2576937710","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576937710?lang=en_us&edition=fundamental","pubTime":"2025-10-18 08:44","pubTimestamp":1760748286,"startTime":"0","endTime":"0","summary":"Fred Aslan, President and CEO of Artiva Biotherapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251018:nNDL4WZ0j7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2576905326","title":"Why Is Artiva Biotherapeutics Stock (ARTV) Up 105% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2576905326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576905326?lang=en_us&edition=fundamental","pubTime":"2025-10-17 21:16","pubTimestamp":1760706984,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics stock saw major gains on Friday alongside a new Fast Track Designation from the FDA.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-artiva-biotherapeutics-stock-artv-up-105-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-artiva-biotherapeutics-stock-artv-up-105-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","BK4585","BK4139","BK4567","IE00BFXG0V08.USD","IE00BYQQ9H92.USD","BK4104","BK4588","FAST","IE00B5TLWC47.USD"],"gpt_icon":0},{"id":"2576534930","title":"Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA), Artiva Biotherapeutics, Inc. (ARTV) and Perspective Therapeutics (CATX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2576534930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576534930?lang=en_us&edition=fundamental","pubTime":"2025-10-17 21:10","pubTimestamp":1760706632,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Taysha Gene Therapies (TSHA – Research Report), Arti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-taysha-gene-therapies-tsha-artiva-biotherapeutics-inc-artv-and-perspective-therapeutics-catx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-taysha-gene-therapies-tsha-artiva-biotherapeutics-inc-artv-and-perspective-therapeutics-catx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","HCSG","LU0029874061.USD","CATX","XLV","BK4581","LABU","BK4585","ARTV","TSHA","BK4137","XBI","BK4139"],"gpt_icon":0},{"id":"2576030667","title":"Wedbush Adjusts Price Target on Artiva Biotherapeutics to $23 From $18, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2576030667","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576030667?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:30","pubTimestamp":1760704257,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics (ARTV) has an average rating of buy and mean price target of $16.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARTV"],"gpt_icon":0},{"id":"2576037868","title":"Artiva Biotherapeutics price target raised to $23 from $18 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2576037868","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576037868?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:00","pubTimestamp":1760702436,"startTime":"0","endTime":"0","summary":"Wedbush raised the firm’s price target on Artiva Biotherapeutics (ARTV) to $23 from $18 and keeps an Outperform rating on the shares. The firm note...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-price-target-raised-to-23-from-18-at-wedbush-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-price-target-raised-to-23-from-18-at-wedbush-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"gpt_icon":0},{"id":"2576034005","title":"BUZZ-U.S. STOCKS ON THE MOVE-Revolution Medicines, Artiva, Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2576034005","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576034005?lang=en_us&edition=fundamental","pubTime":"2025-10-17 19:41","pubTimestamp":1760701294,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Revolution Medicines, Artiva, JefferiesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL6N3VY0JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","LU1582987597.SGD","FITB","LU1023059493.AUD","RIO.UK","LU2346227817.USD","RF","EOG","LU0820561909.HKD","BAC","IE00BFXG1179.USD","LU0122376428.USD","LU2461242641.AUD","IE0034235071.USD","LU1983299246.USD","OZK","COP","RIO.AU","LU0310800379.SGD","ARTV","ZION","LU2491050154.USD","CSX","LU2250418816.HKD","OKE","LU2242649171.HKD","TFC","LU1732799900.SGD","CVX","BHP.AU","SCCO","ET","IE00BJTD4V19.USD","WMB","RVMD","XOM","JEF","LU2491050071.SGD","AXP","LU1582987324.SGD","LU2125154935.USD","BK4213","LU0306807586.USD","LU0345770308.USD","EPD","LU0175139822.USD"],"gpt_icon":1},{"id":"2576393740","title":"Artiva Biotherapeutics Price Target Maintained With a $18.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2576393740","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576393740?lang=en_us&edition=fundamental","pubTime":"2025-10-17 18:44","pubTimestamp":1760697840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 17, 2025 06:44 ET (10:44 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0},{"id":"2576035345","title":"Artiva Biotherapeutics: Strategic Positioning in Rheumatoid Arthritis Market with Promising AlloNK Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2576035345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576035345?lang=en_us&edition=fundamental","pubTime":"2025-10-17 17:55","pubTimestamp":1760694933,"startTime":"0","endTime":"0","summary":"Gil Blum, an analyst from Needham, reiterated the Buy rating on Artiva Biotherapeutics, Inc.. The associated price target remains the same with $18...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/artiva-biotherapeutics-strategic-positioning-in-rheumatoid-arthritis-market-with-promising-allonk-therapy-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/artiva-biotherapeutics-strategic-positioning-in-rheumatoid-arthritis-market-with-promising-allonk-therapy-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2576338130","title":"BUZZ- Artiva surges on US FDA's 'fast track' tag for cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2576338130","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576338130?lang=en_us&edition=fundamental","pubTime":"2025-10-17 17:48","pubTimestamp":1760694531,"startTime":"0","endTime":"0","summary":"BUZZ- Artiva surges on US FDA's 'fast track' tag for cell therapy ** Shares of drug developer Artiva ARTV.O surge 102.5% to $5.57 premarket ** Co on Thursday said U.S. FDA granted fast track designation to its cell therapy AlloNK for treating refractory rheumatoid arthritis** U.S. FDA's \"fast track\" tag aims to speed development and review of drugs for serious conditions with unmet medical need** Refractory rheumatoid arthritis is a chronic joint disease ** Over 20 patients tested with AlloNK plus antibody therapy across autoimmune trials, including RA and lupus- ARTV** Lupus is a chronic autoimmune disease where the body's immune system mistakenly attacks its own tissues and organs ** Co says safety data to highlight tolerability and ease-of-use** Up to last close, stock down ~73%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL3N3VY0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2576038647","title":"Artiva Biotherapeutics Shares Double Premarket on US FDA Fast Track Tag for Its Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2576038647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576038647?lang=en_us&edition=fundamental","pubTime":"2025-10-17 17:31","pubTimestamp":1760693504,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nFWN3VY1PM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2576965778","title":"Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK® in Refractory Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2576965778","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576965778?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:05","pubTimestamp":1760645157,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc. has announced that the U.S. Food and Drug Administration  has granted Fast Track Designation to its investigational therapy AlloNK  for the treatment of refractory rheumatoid arthritis , in combination with rituximab. This marks the first time a drug candidate in the deep B-cell depleting therapeutic category has received this designation for refractory RA. The company is prioritizing refractory RA as the lead indication for AlloNK's development and plans to engage with the FDA in the first half of 2026 to align on pivotal trial design.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on October 16, 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDLb0dBkw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4588","LU0314104364.USD","IE00BKPKM429.USD","BK4585","LU2210149790.SGD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","BK4139","IE00B3QW5Z07.USD","ARTV","BK4112","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2576956778","title":"Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2576956778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576956778?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:05","pubTimestamp":1760645101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA8PTHVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2576787397","title":"Artiva Biotherapeutics Inc - FDA Grants Fast Track Designation to Allonk in Refractory Ra","url":"https://stock-news.laohu8.com/highlight/detail?id=2576787397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576787397?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:05","pubTimestamp":1760645101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA8PTHVK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2562419227","title":"Artiva Biotherapeutics Inc. to Participate in Cantor Global Healthcare Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2562419227","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562419227?lang=en_us&edition=fundamental","pubTime":"2025-08-26 04:05","pubTimestamp":1756152311,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc.  will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on September 3, 2025, at 9:45 a.m. EDT. The clinical-stage biotechnology company focuses on developing cell therapies for autoimmune diseases and cancers. The event includes a live webcast available to the public, with a replay accessible for 90 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDL86LDCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","LU2210149790.SGD","ARTV","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","BK4139","BK4588","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2560132399","title":"Artiva Biotherapeutics CEO Fred Aslan Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2560132399","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560132399?lang=en_us&edition=fundamental","pubTime":"2025-08-19 08:15","pubTimestamp":1755562551,"startTime":"0","endTime":"0","summary":"Fred Aslan, President and CEO of Artiva Biotherapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL3vv45F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2557300202","title":"Artiva Biotherapeutics Inc: Files for Mixed Shelf of up to $300 Mln - Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2557300202","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557300202?lang=en_us&edition=fundamental","pubTime":"2025-08-07 05:16","pubTimestamp":1754515016,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nFWN3TY295:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2557300841","title":"Artiva Biotherapeutics Q2 EPS $(0.87) Misses $(0.80) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557300841","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557300841?lang=en_us&edition=fundamental","pubTime":"2025-08-07 04:57","pubTimestamp":1754513873,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Q2 EPS $(0.87) Misses $(0.80) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46928345/artiva-biotherapeutics-q2-eps-0-87-misses-0-80-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Artiva Biotherapeutics Q2 EPS $(0.87) Misses $(0.80) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0},{"id":"2557300717","title":"Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2557300717","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557300717?lang=en_us&edition=fundamental","pubTime":"2025-08-07 04:05","pubTimestamp":1754510700,"startTime":"0","endTime":"0","summary":"First patient treated in company-sponsored global basket trial exploring AlloNK + rituximab in refractory rheumatoid arthritis, Sjgren’s disease, idiopathic inflammatory myopathies, and systemic scler","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/06/3128667/0/en/Artiva-Biotherapeutics-Reports-Second-Quarter-2025-Financial-Results-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","RA","ARTV","SLE","BK4139"],"gpt_icon":0},{"id":"2546230672","title":"Artiva Biotherapeutics Inc. Concluded Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546230672","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546230672?lang=en_us&edition=fundamental","pubTime":"2025-06-26 04:03","pubTimestamp":1750881795,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics Inc. held its 2025 Annual Meeting of Stockholders on June 24, 2025. During the meeting, stockholders elected Daniel Baker, Ph.D., as a Class I director. The appointment of KPMG LLP as the principal independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An amendment to the 2024 Equity Incentive Plan, increasing the number of shares of common stock authorized for issuance by 1,214,580 shares, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL2lS0y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2542586420","title":"Artiva Biotherapeutics Coverage Assumed by HC Wainwright & Co. at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2542586420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542586420?lang=en_us&edition=fundamental","pubTime":"2025-06-11 19:13","pubTimestamp":1749640380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2025 07:13 ET (11:13 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}]}}